Primary outcomes for sexual behaviour change interventions
| Study | Outcome | OR/RR/SMD |
| (95% CI) | ||
| High-quality trials | ||
| Feldblum35 | STD symptoms | OR 0.67 (0.51 to 0.89) |
| Other trials | ||
| Branson36 | Gonorrhoea | OR 0.92 (0.64 to 1.32) |
| Branson36 | Syphillis | OR 1.80 (0.61 to 5.32) |
| Branson36 | Chlamydia | OR 0.90 (0.60 to 1.36) |
| Cohen 199237 (condom skills) | Reinfection with STI | OR 0.57 (0.34 to 0.96) |
| Cohen 199237 (condom distribution) | Reinfection with STI | OR 0.91 (0.58 to 1.44) |
| Cohen 199237 (condom social influences) | Reinfection with STI | OR 0.97 (0.60 to 1.56) |
| Diclemente38 | Chlamydia | OR 0.17 (0.03 to 0.09)* |
| Explore39 | HIV | OR 0.79 (0.61 to 1.02) |
| Gollub40 | Probable STI | OR 1.09 (0.60 to 1.99) |
| Harvey41 | Treated for STD in last 6 months | OR 0.96 (0.74 to 1.23) |
| Kamali42 | HIV rate (PY) | RR 1.00 (0.87 to 1.16) |
| Kamali42 | Gonorrhoea rate (PY) | RR 0.43 (0.32 to 0.59) |
| Kamali42 | Chlamydia rate (PY) | RR 1.06 (0.88 to 1.27) |
| Kamali42 | CHSV2 rate (PY) | RR 1.04 (0.93 to 1.17) |
| Kamali42 | Active syphilis rate (PY) | RR 7.01 (5.82 to 8.51) |
| Shain43 | Chlamydia or gonorrhoea | OR 0.8 (0.55 to 1.16) |
Results in italics are for studies with factorial design or those where more than one comparison group tested against a single control has been included.
↵* These are the results reported in the paper, which adjusted for baseline variables and covariates.
PY, per year; STD, sexually transmitted disease; STI, sexually transmitted infection.